Latest Share Placements News

Kali Metals has successfully raised $1.2 million through a discounted share placement, aiming to boost exploration at its Marble Bar and Higginsville projects. The capital injection signals renewed momentum for the company’s gold and lithium ambitions.

Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.

The Takeovers Panel has declined to investigate alleged breaches related to Yowie Group’s recent share placement and funding arrangements, finding no material impact on company control or disclosure issues.

Prescient Therapeutics reported an 11.1% reduction in net loss for FY2025, progressing its lead candidate PTX-100 into Phase 2a trials with FDA Fast Track and Orphan Drug designations, supported by a recent $9.8 million capital raise.

Marquee Resources has successfully closed an oversubscribed $2.51 million placement, underscoring strong investor confidence as it prepares for the next phase of drilling at its Mt Clement Antimony Project.

Unico Silver Limited has raised $25 million through a share placement to accelerate drilling and resource upgrades at its key silver projects in Argentina, aiming to define a major silver equivalent resource.

Rokeby Resources has secured $1.7 million through an oversubscribed share placement to fund expanded drilling at its promising Hurricane gold and antimony project in Queensland.

West Cobar Metals has successfully raised $1.25 million through a discounted share placement, aiming to boost drilling and testwork across its gold and critical minerals projects.

Anson Resources has successfully raised $5 million through an oversubscribed share placement to fast-track development of its Green River Lithium Project in Utah. The funds will support key engineering, permitting, and resource expansion activities.

OD6 Metals has raised $2.5 million through a strongly supported placement to fast-track rare earth testwork and copper drilling programs at its flagship Australian projects.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.

Botala Energy has raised A$1.5 million through a discounted share placement to fund critical drilling and feasibility work at its Serowe CBM Project in Botswana. Directors and the CEO are backing the raise, signaling confidence in the project’s potential.